Company page

Xeno Transplants Corporation

Xeno Transplants Corporation, trading under the ticker XENO, is a public company based in the United States with a market capitalization of approximately $4.04 billion. The company focuses on innovative solutions in the field of organ transplantation. Xeno aims to address the challenges associated with organ shortages and improve patient outcomes through its advanced technologies.

profileXENOAI content: aiUpdated May 29, 2026/company/xeno-transplants-corporation
Xeno Transplants Corporation logo
Ticker
XENO
Market cap
$4,036
Sector
Health Technology
Industry
Biotechnology